

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 4.11516769 |
| 2 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.96483676 |
| 3 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.87850990 |
| 4 | apoptotic cell clearance (GO:0043277) | 3.86802322 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 3.58730315 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 3.58730315 |
| 7 | barbed-end actin filament capping (GO:0051016) | 3.49434214 |
| 8 | regulation of cholesterol homeostasis (GO:2000188) | 3.47585782 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 3.39165234 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 3.27525080 |
| 11 | * semaphorin-plexin signaling pathway (GO:0071526) | 3.26080058 |
| 12 | adherens junction assembly (GO:0034333) | 3.20543931 |
| 13 | cell-cell junction maintenance (GO:0045217) | 3.14507303 |
| 14 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.14382885 |
| 15 | regulation of extracellular matrix disassembly (GO:0010715) | 3.12845621 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 3.12544784 |
| 17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.09603122 |
| 18 | hemidesmosome assembly (GO:0031581) | 3.09173294 |
| 19 | activation of Rac GTPase activity (GO:0032863) | 3.05747124 |
| 20 | epithelial cell-cell adhesion (GO:0090136) | 3.04303727 |
| 21 | focal adhesion assembly (GO:0048041) | 3.03839553 |
| 22 | cell-substrate adherens junction assembly (GO:0007045) | 3.03839553 |
| 23 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.02858414 |
| 24 | endothelial cell chemotaxis (GO:0035767) | 3.02198588 |
| 25 | 4-hydroxyproline metabolic process (GO:0019471) | 3.02001151 |
| 26 | protein carboxylation (GO:0018214) | 2.98370164 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.98370164 |
| 28 | negative regulation of fatty acid transport (GO:2000192) | 2.94831851 |
| 29 | skin morphogenesis (GO:0043589) | 2.94605534 |
| 30 | positive regulation of receptor recycling (GO:0001921) | 2.93366209 |
| 31 | basement membrane organization (GO:0071711) | 2.91531815 |
| 32 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.90405541 |
| 33 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.89446891 |
| 34 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.89308824 |
| 35 | endodermal cell differentiation (GO:0035987) | 2.87925124 |
| 36 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.86941612 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 2.86699519 |
| 38 | regulation of hippo signaling (GO:0035330) | 2.83165058 |
| 39 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.82824673 |
| 40 | lysine metabolic process (GO:0006553) | 2.79021463 |
| 41 | lysine catabolic process (GO:0006554) | 2.79021463 |
| 42 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.78111766 |
| 43 | axon extension involved in axon guidance (GO:0048846) | 2.76394391 |
| 44 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.76394391 |
| 45 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.75623524 |
| 46 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.74592769 |
| 47 | response to laminar fluid shear stress (GO:0034616) | 2.74145224 |
| 48 | positive regulation of nuclease activity (GO:0032075) | 2.70897400 |
| 49 | atrioventricular valve morphogenesis (GO:0003181) | 2.69830359 |
| 50 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.69052965 |
| 51 | low-density lipoprotein particle clearance (GO:0034383) | 2.68563889 |
| 52 | positive regulation of p38MAPK cascade (GO:1900745) | 2.68155359 |
| 53 | apoptotic process involved in morphogenesis (GO:0060561) | 2.67774808 |
| 54 | hypotonic response (GO:0006971) | 2.66579531 |
| 55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.66487337 |
| 56 | regulation of early endosome to late endosome transport (GO:2000641) | 2.65553558 |
| 57 | surfactant homeostasis (GO:0043129) | 2.64684161 |
| 58 | complement activation, alternative pathway (GO:0006957) | 2.62863601 |
| 59 | lung epithelium development (GO:0060428) | 2.62475015 |
| 60 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.62010528 |
| 61 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.60894156 |
| 62 | hippo signaling (GO:0035329) | 2.60653340 |
| 63 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.60105856 |
| 64 | collagen fibril organization (GO:0030199) | 2.59970323 |
| 65 | pinocytosis (GO:0006907) | 2.59378188 |
| 66 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57859329 |
| 67 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.57723161 |
| 68 | plasma membrane repair (GO:0001778) | 2.56564992 |
| 69 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.56527195 |
| 70 | negative regulation of lipid transport (GO:0032369) | 2.56320902 |
| 71 | lipoprotein metabolic process (GO:0042157) | 2.56051094 |
| 72 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.55955884 |
| 73 | maternal placenta development (GO:0001893) | 2.55072385 |
| 74 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.54558404 |
| 75 | midgut development (GO:0007494) | 2.54321519 |
| 76 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.52864383 |
| 77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.52343254 |
| 78 | L-phenylalanine catabolic process (GO:0006559) | 2.52343254 |
| 79 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.52229029 |
| 80 | regulation of extracellular matrix organization (GO:1903053) | 2.52112404 |
| 81 | glyoxylate metabolic process (GO:0046487) | 2.52061398 |
| 82 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51853512 |
| 83 | protein retention in ER lumen (GO:0006621) | 2.51783063 |
| 84 | L-phenylalanine metabolic process (GO:0006558) | 2.51684361 |
| 85 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.51684361 |
| 86 | macroautophagy (GO:0016236) | 2.51657531 |
| 87 | establishment of apical/basal cell polarity (GO:0035089) | 2.51082293 |
| 88 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.50575373 |
| 89 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.49860751 |
| 90 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.49805603 |
| 91 | regulation of fibrinolysis (GO:0051917) | 2.49461355 |
| 92 | negative regulation of cell size (GO:0045792) | 2.49097682 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48621046 |
| 94 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.47921503 |
| 95 | regulation of water loss via skin (GO:0033561) | 2.47907113 |
| 96 | regulation of apoptotic cell clearance (GO:2000425) | 2.46885628 |
| 97 | cell-substrate junction assembly (GO:0007044) | 2.46756675 |
| 98 | urea metabolic process (GO:0019627) | 2.46435891 |
| 99 | urea cycle (GO:0000050) | 2.46435891 |
| 100 | regulation of protein activation cascade (GO:2000257) | 2.46068285 |
| 101 | renal system development (GO:0072001) | 2.45797210 |
| 102 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.45553884 |
| 103 | negative regulation of cholesterol transport (GO:0032375) | 2.45036783 |
| 104 | negative regulation of sterol transport (GO:0032372) | 2.45036783 |
| 105 | cell volume homeostasis (GO:0006884) | 2.44499725 |
| 106 | regulation of cholesterol storage (GO:0010885) | 2.44323151 |
| 107 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.43333831 |
| 108 | regulation of establishment of planar polarity (GO:0090175) | 2.43038105 |
| 109 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.41649140 |
| 110 | cellular response to unfolded protein (GO:0034620) | 2.41046927 |
| 111 | cellular response to vitamin (GO:0071295) | 2.40024043 |
| 112 | regulation of complement activation (GO:0030449) | 2.39712276 |
| 113 | cell junction maintenance (GO:0034331) | 2.39657086 |
| 114 | stress fiber assembly (GO:0043149) | 2.39134340 |
| 115 | homocysteine metabolic process (GO:0050667) | 2.38986306 |
| 116 | ER-nucleus signaling pathway (GO:0006984) | 2.38586969 |
| 117 | regulation of nuclease activity (GO:0032069) | 2.38060365 |
| 118 | actin filament bundle organization (GO:0061572) | 2.37912008 |
| 119 | actin filament bundle assembly (GO:0051017) | 2.37912008 |
| 120 | phospholipid homeostasis (GO:0055091) | 2.37543832 |
| 121 | regulation of p38MAPK cascade (GO:1900744) | 2.37536131 |
| 122 | polarized epithelial cell differentiation (GO:0030859) | 2.36812549 |
| 123 | mannose metabolic process (GO:0006013) | 2.36433153 |
| 124 | extracellular matrix disassembly (GO:0022617) | 2.36324938 |
| 125 | membrane protein ectodomain proteolysis (GO:0006509) | 2.36136911 |
| 126 | cellular response to vitamin D (GO:0071305) | 2.35745794 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 2.35418385 |
| 128 | plasma lipoprotein particle clearance (GO:0034381) | 2.34738765 |
| 129 | COPII vesicle coating (GO:0048208) | 2.33799095 |
| 130 | adhesion of symbiont to host (GO:0044406) | 2.33781043 |
| 131 | cellular modified amino acid catabolic process (GO:0042219) | 2.32734472 |
| 132 | intestinal cholesterol absorption (GO:0030299) | 2.32144142 |
| 133 | embryonic foregut morphogenesis (GO:0048617) | 2.31845916 |
| 134 | positive regulation of fatty acid oxidation (GO:0046321) | 2.31496238 |
| 135 | ear development (GO:0043583) | 2.31454650 |
| 136 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.30997710 |
| 137 | cellular response to nutrient (GO:0031670) | 2.30519684 |
| 138 | peptide catabolic process (GO:0043171) | 2.30086811 |
| 139 | Rho protein signal transduction (GO:0007266) | 2.30054588 |
| 140 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.29541509 |
| 141 | reverse cholesterol transport (GO:0043691) | 2.29104969 |
| 142 | collagen metabolic process (GO:0032963) | 2.29026531 |
| 143 | gastrulation with mouth forming second (GO:0001702) | 2.28403248 |
| 144 | protein localization to endosome (GO:0036010) | 2.28301102 |
| 145 | renal filtration (GO:0097205) | 2.28107567 |
| 146 | embryo implantation (GO:0007566) | 2.28046070 |
| 147 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.27725239 |
| 148 | blood vessel endothelial cell migration (GO:0043534) | 2.27674149 |
| 149 | protein heterotrimerization (GO:0070208) | 2.27008869 |
| 150 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.26891337 |
| 151 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.26482325 |
| 152 | positive regulation of glycogen metabolic process (GO:0070875) | 2.25428176 |
| 153 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.22151193 |
| 154 | amyloid precursor protein catabolic process (GO:0042987) | 2.21881219 |
| 155 | embryonic process involved in female pregnancy (GO:0060136) | 2.20930443 |
| 156 | multicellular organismal water homeostasis (GO:0050891) | 2.20614192 |
| 157 | collagen catabolic process (GO:0030574) | 2.20308974 |
| 158 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.20017918 |
| 159 | response to fluid shear stress (GO:0034405) | 2.18098795 |
| 160 | glomerular basement membrane development (GO:0032836) | 2.17228538 |
| 161 | virion attachment to host cell (GO:0019062) | 2.16893213 |
| 162 | adhesion of symbiont to host cell (GO:0044650) | 2.16893213 |
| 163 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.16491722 |
| 164 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.16365477 |
| 165 | establishment of monopolar cell polarity (GO:0061162) | 2.16365477 |
| 166 | endocytic recycling (GO:0032456) | 2.14872536 |
| 167 | negative regulation of viral release from host cell (GO:1902187) | 2.14732473 |
| 168 | glial cell migration (GO:0008347) | 2.13118379 |
| 169 | positive regulation of histone deacetylation (GO:0031065) | 2.12493809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.85783755 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.37752870 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38509908 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.30584497 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13581532 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.06878168 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.06478625 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.00316672 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.81417764 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.50495026 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.22846955 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.21670247 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.11887037 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.09149274 |
| 15 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.03130810 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00136743 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96632571 |
| 18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.94280877 |
| 19 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.82182751 |
| 20 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.80408840 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80387932 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.80081317 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79826677 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.78696751 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78431367 |
| 26 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70051284 |
| 27 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68531457 |
| 28 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.65779231 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65186162 |
| 30 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.63667087 |
| 31 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.62052564 |
| 32 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57034178 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56758626 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55105823 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50046793 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.49938207 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.48691683 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48187254 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48184418 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.47857036 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47101161 |
| 42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46943136 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46315989 |
| 44 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45727423 |
| 45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.45124587 |
| 46 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43625401 |
| 47 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40487999 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40215743 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.39761372 |
| 50 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.39550076 |
| 51 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.39135732 |
| 52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.39135732 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37514347 |
| 54 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36372815 |
| 55 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35396505 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31031434 |
| 57 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.31005324 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30662141 |
| 59 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.29600794 |
| 60 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.27485087 |
| 61 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27017321 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25825790 |
| 63 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.25402391 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25204653 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24957768 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.23920226 |
| 67 | P68_20966046_ChIP-Seq_HELA_Human | 1.22916801 |
| 68 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22859428 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.22342822 |
| 70 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.22285849 |
| 71 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20648464 |
| 72 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20040634 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18468912 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18428478 |
| 75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18071005 |
| 76 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17187254 |
| 77 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16420882 |
| 78 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16420882 |
| 79 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16273336 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14718641 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13976826 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13356728 |
| 83 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.12887073 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12752173 |
| 85 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.12011291 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11447363 |
| 87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11367681 |
| 88 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11184504 |
| 89 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10530955 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10472523 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10127857 |
| 92 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09742396 |
| 93 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09475592 |
| 94 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.09303964 |
| 95 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06924509 |
| 96 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06495690 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06161149 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05258788 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04352522 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03982668 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03673473 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03269942 |
| 103 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03120892 |
| 104 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02376558 |
| 105 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01937208 |
| 106 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01646031 |
| 107 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01507699 |
| 108 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01451598 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01215620 |
| 110 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00650714 |
| 111 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99710881 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99683371 |
| 113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99484432 |
| 114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98948957 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98685546 |
| 116 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97930883 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97276058 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96807988 |
| 119 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95638229 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94833136 |
| 121 | MYC_22102868_ChIP-Seq_BL_Human | 0.94002789 |
| 122 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.92312155 |
| 123 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90697148 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89045772 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89043332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.49672103 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.45585657 |
| 3 | MP0005360_urolithiasis | 3.07235743 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.03942450 |
| 5 | MP0003252_abnormal_bile_duct | 2.65958095 |
| 6 | MP0005275_abnormal_skin_tensile | 2.32525643 |
| 7 | MP0009840_abnormal_foam_cell | 2.32412737 |
| 8 | MP0003566_abnormal_cell_adhesion | 2.23017498 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.21991318 |
| 10 | MP0005365_abnormal_bile_salt | 2.20353021 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.19323377 |
| 12 | MP0003283_abnormal_digestive_organ | 2.17119655 |
| 13 | MP0005409_darkened_coat_color | 2.09561847 |
| 14 | MP0004272_abnormal_basement_membrane | 2.04213482 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.02916959 |
| 16 | MP0005257_abnormal_intraocular_pressure | 1.93507639 |
| 17 | MP0009053_abnormal_anal_canal | 1.84316664 |
| 18 | MP0000537_abnormal_urethra_morphology | 1.82724598 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.79758151 |
| 20 | MP0001958_emphysema | 1.79294303 |
| 21 | MP0005076_abnormal_cell_differentiation | 1.78645445 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.71644681 |
| 23 | MP0009384_cardiac_valve_regurgitation | 1.71326785 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.70599467 |
| 25 | MP0001849_ear_inflammation | 1.70493246 |
| 26 | MP0008260_abnormal_autophagy | 1.66997520 |
| 27 | MP0005451_abnormal_body_composition | 1.65541139 |
| 28 | MP0010352_gastrointestinal_tract_polyps | 1.64701073 |
| 29 | MP0006054_spinal_hemorrhage | 1.62116478 |
| 30 | MP0000566_synostosis | 1.57394726 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54127775 |
| 32 | MP0005083_abnormal_biliary_tract | 1.54123908 |
| 33 | MP0003279_aneurysm | 1.51972850 |
| 34 | MP0002896_abnormal_bone_mineralization | 1.51263439 |
| 35 | MP0000858_altered_metastatic_potential | 1.49913435 |
| 36 | MP0010329_abnormal_lipoprotein_level | 1.46281606 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.46276598 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.46043579 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.44154158 |
| 40 | MP0002249_abnormal_larynx_morphology | 1.42832336 |
| 41 | MP0005023_abnormal_wound_healing | 1.42016711 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.37834933 |
| 43 | MP0003115_abnormal_respiratory_system | 1.32969706 |
| 44 | MP0005501_abnormal_skin_physiology | 1.32815220 |
| 45 | MP0000579_abnormal_nail_morphology | 1.29672337 |
| 46 | MP0000733_abnormal_muscle_development | 1.29061263 |
| 47 | MP0003091_abnormal_cell_migration | 1.28923706 |
| 48 | MP0002060_abnormal_skin_morphology | 1.24919126 |
| 49 | MP0005503_abnormal_tendon_morphology | 1.24356047 |
| 50 | MP0004947_skin_inflammation | 1.23357567 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.22755428 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.21591878 |
| 53 | MP0002234_abnormal_pharynx_morphology | 1.20151996 |
| 54 | MP0000751_myopathy | 1.19723031 |
| 55 | MP0002098_abnormal_vibrissa_morphology | 1.17034053 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 1.16039124 |
| 57 | MP0000534_abnormal_ureter_morphology | 1.15545359 |
| 58 | MP0003195_calcinosis | 1.14653319 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.14611277 |
| 60 | MP0003436_decreased_susceptibility_to | 1.14027139 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.13824391 |
| 62 | MP0005248_abnormal_Harderian_gland | 1.11939801 |
| 63 | MP0002928_abnormal_bile_duct | 1.11032322 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.09630712 |
| 65 | MP0001216_abnormal_epidermal_layer | 1.08312852 |
| 66 | MP0003329_amyloid_beta_deposits | 1.07168287 |
| 67 | MP0000767_abnormal_smooth_muscle | 1.06904813 |
| 68 | MP0002168_other_aberrant_phenotype | 1.06482908 |
| 69 | MP0004858_abnormal_nervous_system | 1.05295037 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.04686481 |
| 71 | MP0002254_reproductive_system_inflammat | 1.03482976 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 1.01766706 |
| 73 | MP0000609_abnormal_liver_physiology | 1.01564594 |
| 74 | MP0000762_abnormal_tongue_morphology | 1.01524519 |
| 75 | MP0000467_abnormal_esophagus_morphology | 1.01393926 |
| 76 | MP0003045_fibrosis | 1.01327655 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 1.00749851 |
| 78 | MP0003942_abnormal_urinary_system | 1.00427099 |
| 79 | MP0001915_intracranial_hemorrhage | 0.98947052 |
| 80 | MP0005508_abnormal_skeleton_morphology | 0.97819441 |
| 81 | MP0009643_abnormal_urine_homeostasis | 0.97372917 |
| 82 | MP0002092_abnormal_eye_morphology | 0.95995115 |
| 83 | MP0002697_abnormal_eye_size | 0.94353307 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.94154079 |
| 85 | MP0000428_abnormal_craniofacial_morphol | 0.94010244 |
| 86 | MP0000569_abnormal_digit_pigmentation | 0.92696275 |
| 87 | MP0000462_abnormal_digestive_system | 0.92183288 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.91716125 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.91198498 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.90466798 |
| 91 | MP0005390_skeleton_phenotype | 0.89569526 |
| 92 | MP0002282_abnormal_trachea_morphology | 0.88722702 |
| 93 | MP0003941_abnormal_skin_development | 0.87400747 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.87152261 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.86948937 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.84755330 |
| 97 | MP0005332_abnormal_amino_acid | 0.83746007 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.81542252 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.81302367 |
| 100 | MP0001542_abnormal_bone_strength | 0.81263708 |
| 101 | MP0009278_abnormal_bone_marrow | 0.80603302 |
| 102 | MP0003385_abnormal_body_wall | 0.80515986 |
| 103 | MP0003075_altered_response_to | 0.80041989 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.79315460 |
| 105 | MP0005197_abnormal_uvea_morphology | 0.79148775 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.79086430 |
| 107 | MP0010771_integument_phenotype | 0.78268831 |
| 108 | MP0004084_abnormal_cardiac_muscle | 0.77858686 |
| 109 | MP0000681_abnormal_thyroid_gland | 0.77857261 |
| 110 | MP0005164_abnormal_response_to | 0.77601868 |
| 111 | MP0005670_abnormal_white_adipose | 0.77364924 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.76448027 |
| 113 | MP0002796_impaired_skin_barrier | 0.76336547 |
| 114 | MP0003828_pulmonary_edema | 0.75992219 |
| 115 | MP0010630_abnormal_cardiac_muscle | 0.75444771 |
| 116 | MP0009931_abnormal_skin_appearance | 0.75136948 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.74998056 |
| 118 | MP0005187_abnormal_penis_morphology | 0.74412521 |
| 119 | MP0000163_abnormal_cartilage_morphology | 0.74337267 |
| 120 | MP0001756_abnormal_urination | 0.73713474 |
| 121 | MP0000604_amyloidosis | 0.73285876 |
| 122 | MP0000598_abnormal_liver_morphology | 0.73025706 |
| 123 | MP0006138_congestive_heart_failure | 0.72846557 |
| 124 | MP0003303_peritoneal_inflammation | 0.72818206 |
| 125 | MP0000013_abnormal_adipose_tissue | 0.72108699 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.72077712 |
| 127 | MP0003448_altered_tumor_morphology | 0.72027880 |
| 128 | MP0005621_abnormal_cell_physiology | 0.71500422 |
| 129 | MP0002295_abnormal_pulmonary_circulatio | 0.71444876 |
| 130 | MP0000377_abnormal_hair_follicle | 0.71317896 |
| 131 | MP0002135_abnormal_kidney_morphology | 0.70024092 |
| 132 | MP0004510_myositis | 0.69988075 |
| 133 | MP0000627_abnormal_mammary_gland | 0.69977998 |
| 134 | MP0002933_joint_inflammation | 0.69780477 |
| 135 | MP0004883_abnormal_blood_vessel | 0.69438199 |
| 136 | MP0001614_abnormal_blood_vessel | 0.69374815 |
| 137 | MP0002128_abnormal_blood_circulation | 0.69140382 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.69044438 |
| 139 | MP0002115_abnormal_skeleton_extremities | 0.68262276 |
| 140 | MP0001243_abnormal_dermal_layer | 0.68241967 |
| 141 | MP0001944_abnormal_pancreas_morphology | 0.67927431 |
| 142 | MP0002113_abnormal_skeleton_development | 0.67860200 |
| 143 | MP0003795_abnormal_bone_structure | 0.66486071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 4.03460416 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.00148753 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.72788672 |
| 4 | Shallow orbits (HP:0000586) | 3.72446181 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.43834771 |
| 6 | Broad face (HP:0000283) | 3.38743082 |
| 7 | Complement deficiency (HP:0004431) | 3.00150817 |
| 8 | Atrophic scars (HP:0001075) | 2.98461678 |
| 9 | Ankle contracture (HP:0006466) | 2.87707850 |
| 10 | Aortic aneurysm (HP:0004942) | 2.85373319 |
| 11 | Obstructive sleep apnea (HP:0002870) | 2.81786549 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 2.78257388 |
| 13 | Mitral valve prolapse (HP:0001634) | 2.75889778 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 2.75547294 |
| 15 | Vertebral compression fractures (HP:0002953) | 2.75428699 |
| 16 | Xanthomatosis (HP:0000991) | 2.74751559 |
| 17 | Aortic dissection (HP:0002647) | 2.73542363 |
| 18 | Broad metatarsal (HP:0001783) | 2.65376412 |
| 19 | Cervical subluxation (HP:0003308) | 2.65309840 |
| 20 | Aneurysm (HP:0002617) | 2.62323541 |
| 21 | Lymphangioma (HP:0100764) | 2.61380660 |
| 22 | Peritonitis (HP:0002586) | 2.53876300 |
| 23 | Abnormality of complement system (HP:0005339) | 2.52235101 |
| 24 | Bladder diverticulum (HP:0000015) | 2.48761548 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.44779525 |
| 26 | Distal lower limb amyotrophy (HP:0008944) | 2.41810756 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38064217 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.38064217 |
| 29 | Hand muscle atrophy (HP:0009130) | 2.36042295 |
| 30 | Distal upper limb amyotrophy (HP:0007149) | 2.36034395 |
| 31 | Upper limb amyotrophy (HP:0009129) | 2.36034395 |
| 32 | Turricephaly (HP:0000262) | 2.35966814 |
| 33 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32584373 |
| 34 | Thin bony cortex (HP:0002753) | 2.30021282 |
| 35 | Dilatation of the ascending aorta (HP:0005111) | 2.29573188 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.24990722 |
| 37 | Glomerulonephritis (HP:0000099) | 2.24488434 |
| 38 | Blue sclerae (HP:0000592) | 2.22962898 |
| 39 | Fragile skin (HP:0001030) | 2.22920013 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.21187869 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.21187869 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.21187869 |
| 43 | Long toe (HP:0010511) | 2.20981651 |
| 44 | Natal tooth (HP:0000695) | 2.19583165 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.19569356 |
| 46 | Arterial tortuosity (HP:0005116) | 2.17984785 |
| 47 | Biconcave vertebral bodies (HP:0004586) | 2.17336959 |
| 48 | J-shaped sella turcica (HP:0002680) | 2.16517918 |
| 49 | Stridor (HP:0010307) | 2.16263942 |
| 50 | Hemorrhage of the eye (HP:0011885) | 2.14690788 |
| 51 | Myocardial infarction (HP:0001658) | 2.13238796 |
| 52 | Vascular tortuosity (HP:0004948) | 2.12911601 |
| 53 | Mitral regurgitation (HP:0001653) | 2.11382082 |
| 54 | Advanced eruption of teeth (HP:0006288) | 2.09816008 |
| 55 | Hyperacusis (HP:0010780) | 2.09465531 |
| 56 | Increased connective tissue (HP:0009025) | 2.08380168 |
| 57 | Spinal rigidity (HP:0003306) | 2.07968852 |
| 58 | Nephritis (HP:0000123) | 2.06545424 |
| 59 | Ulnar bowing (HP:0003031) | 2.05873036 |
| 60 | Back pain (HP:0003418) | 2.05758441 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.04754459 |
| 62 | Disproportionate tall stature (HP:0001519) | 2.03675241 |
| 63 | Abnormality of dentin (HP:0010299) | 2.03422357 |
| 64 | Skin nodule (HP:0200036) | 2.02096653 |
| 65 | Spondylolisthesis (HP:0003302) | 2.01041737 |
| 66 | Nuclear cataract (HP:0100018) | 2.01025032 |
| 67 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.00944110 |
| 68 | Focal segmental glomerulosclerosis (HP:0000097) | 2.00630983 |
| 69 | Flat acetabular roof (HP:0003180) | 1.99358154 |
| 70 | Joint stiffness (HP:0001387) | 1.98520437 |
| 71 | Achilles tendon contracture (HP:0001771) | 1.98107179 |
| 72 | Esophageal varix (HP:0002040) | 1.96892204 |
| 73 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.96429800 |
| 74 | Short 4th metacarpal (HP:0010044) | 1.96429800 |
| 75 | Short nail (HP:0001799) | 1.96412575 |
| 76 | Subacute progressive viral hepatitis (HP:0006572) | 1.92640303 |
| 77 | Striae distensae (HP:0001065) | 1.92534151 |
| 78 | Genu recurvatum (HP:0002816) | 1.92324041 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 1.92316157 |
| 80 | Hypoalphalipoproteinemia (HP:0003233) | 1.91422734 |
| 81 | Hypoglycemic coma (HP:0001325) | 1.90746589 |
| 82 | Spastic diplegia (HP:0001264) | 1.90115905 |
| 83 | Joint laxity (HP:0001388) | 1.89746430 |
| 84 | Abnormality of the acetabulum (HP:0003170) | 1.89569962 |
| 85 | Deviation of the hallux (HP:0010051) | 1.89211950 |
| 86 | Coxa vara (HP:0002812) | 1.87722343 |
| 87 | Absent frontal sinuses (HP:0002688) | 1.86851937 |
| 88 | Hallux valgus (HP:0001822) | 1.86132465 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 1.85641879 |
| 90 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85522581 |
| 91 | Milia (HP:0001056) | 1.85082341 |
| 92 | Soft skin (HP:0000977) | 1.85065323 |
| 93 | Hematochezia (HP:0002573) | 1.84975887 |
| 94 | Abnormal ossification of hand bones (HP:0005921) | 1.84624134 |
| 95 | Atelectasis (HP:0100750) | 1.84434975 |
| 96 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.82350153 |
| 97 | Enlarged penis (HP:0000040) | 1.81553005 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 1.81212620 |
| 99 | Camptodactyly of toe (HP:0001836) | 1.81155568 |
| 100 | Abnormality of the common coagulation pathway (HP:0010990) | 1.80612096 |
| 101 | Increased cerebral lipofuscin (HP:0011813) | 1.80556688 |
| 102 | Abnormality of carpal bone ossification (HP:0006257) | 1.80357080 |
| 103 | Abnormality of the 4th metacarpal (HP:0010012) | 1.80305282 |
| 104 | Abnormality of the thoracic spine (HP:0100711) | 1.79641211 |
| 105 | Renovascular hypertension (HP:0100817) | 1.79496507 |
| 106 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79463517 |
| 107 | Osteolytic defects of the hand bones (HP:0009699) | 1.79463517 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79368407 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79368407 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79368407 |
| 111 | Aortic regurgitation (HP:0001659) | 1.78644233 |
| 112 | Malnutrition (HP:0004395) | 1.78598180 |
| 113 | Bowel diverticulosis (HP:0005222) | 1.78213001 |
| 114 | Axonal loss (HP:0003447) | 1.76834164 |
| 115 | Ketoacidosis (HP:0001993) | 1.76008390 |
| 116 | Neurofibrillary tangles (HP:0002185) | 1.75409524 |
| 117 | Glomerulosclerosis (HP:0000096) | 1.74695678 |
| 118 | Mitral stenosis (HP:0001718) | 1.74462673 |
| 119 | Bowed forearm bones (HP:0003956) | 1.73037408 |
| 120 | Bowing of the arm (HP:0006488) | 1.73037408 |
| 121 | Neonatal short-limb short stature (HP:0008921) | 1.72625973 |
| 122 | Elbow flexion contracture (HP:0002987) | 1.71147437 |
| 123 | Cerebral inclusion bodies (HP:0100314) | 1.70790807 |
| 124 | Wrist flexion contracture (HP:0001239) | 1.70153576 |
| 125 | Hyperextensible skin (HP:0000974) | 1.69408145 |
| 126 | Late onset (HP:0003584) | 1.68263679 |
| 127 | Bronchomalacia (HP:0002780) | 1.68236379 |
| 128 | Elfin facies (HP:0004428) | 1.68082835 |
| 129 | Exostoses (HP:0100777) | 1.67977097 |
| 130 | Ectopia lentis (HP:0001083) | 1.67200575 |
| 131 | Asymmetry of the thorax (HP:0001555) | 1.67106923 |
| 132 | Renal duplication (HP:0000075) | 1.66867989 |
| 133 | Wormian bones (HP:0002645) | 1.66812466 |
| 134 | Scapular winging (HP:0003691) | 1.66794623 |
| 135 | Tibial bowing (HP:0002982) | 1.66659335 |
| 136 | Gout (HP:0001997) | 1.66129400 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66059824 |
| 138 | Loss of speech (HP:0002371) | 1.65288976 |
| 139 | Hydroxyprolinuria (HP:0003080) | 1.65191191 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 1.65191191 |
| 141 | Long palpebral fissure (HP:0000637) | 1.63942923 |
| 142 | Radial bowing (HP:0002986) | 1.63831616 |
| 143 | Epidermoid cyst (HP:0200040) | 1.63495781 |
| 144 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.63345295 |
| 145 | Spinal cord compression (HP:0002176) | 1.62398561 |
| 146 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.61198842 |
| 147 | Difficulty climbing stairs (HP:0003551) | 1.60739717 |
| 148 | Abnormal vertebral ossification (HP:0100569) | 1.59736161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.92435137 |
| 2 | PKN2 | 3.69110177 |
| 3 | ERN1 | 3.37183048 |
| 4 | RIPK1 | 3.14755925 |
| 5 | TTN | 2.87305557 |
| 6 | SIK1 | 2.75011866 |
| 7 | PTK6 | 2.72635557 |
| 8 | SMG1 | 2.58393717 |
| 9 | PDGFRA | 2.47812186 |
| 10 | LATS1 | 2.40451085 |
| 11 | EPHB2 | 2.28587007 |
| 12 | MAP3K10 | 2.24420001 |
| 13 | TGFBR2 | 2.15979081 |
| 14 | EPHA2 | 2.10557720 |
| 15 | DDR2 | 2.06200870 |
| 16 | PAK4 | 1.95035530 |
| 17 | PRPF4B | 1.85226574 |
| 18 | EEF2K | 1.83127450 |
| 19 | IRAK3 | 1.81421955 |
| 20 | PTK2 | 1.70612986 |
| 21 | CAMK1D | 1.68634475 |
| 22 | ICK | 1.62126177 |
| 23 | FGFR4 | 1.60478395 |
| 24 | MAPK15 | 1.45781239 |
| 25 | PRKD2 | 1.42455114 |
| 26 | MST1R | 1.41117325 |
| 27 | CAMK1G | 1.38783227 |
| 28 | MET | 1.34483375 |
| 29 | PAK2 | 1.34253552 |
| 30 | FER | 1.28962463 |
| 31 | LRRK2 | 1.28174809 |
| 32 | MTOR | 1.26403982 |
| 33 | BMX | 1.22127122 |
| 34 | DYRK1B | 1.22126133 |
| 35 | EPHB1 | 1.19572252 |
| 36 | MARK2 | 1.18942972 |
| 37 | MAP3K6 | 1.16234792 |
| 38 | TAOK1 | 1.12162023 |
| 39 | CDK12 | 1.07929565 |
| 40 | ERBB2 | 1.07718238 |
| 41 | CDK6 | 1.03180556 |
| 42 | SCYL2 | 1.02558881 |
| 43 | MAP2K2 | 0.95973751 |
| 44 | LMTK2 | 0.94384992 |
| 45 | FRK | 0.92543040 |
| 46 | INSRR | 0.91406885 |
| 47 | PDGFRB | 0.88389766 |
| 48 | MAP3K13 | 0.87844895 |
| 49 | TAOK3 | 0.87631974 |
| 50 | MAP3K3 | 0.87598960 |
| 51 | NEK9 | 0.86635615 |
| 52 | PDPK1 | 0.85193124 |
| 53 | PAK3 | 0.83895455 |
| 54 | STK3 | 0.83290852 |
| 55 | NTRK1 | 0.82633980 |
| 56 | PASK | 0.80867957 |
| 57 | MYLK | 0.80643858 |
| 58 | LATS2 | 0.80624994 |
| 59 | DMPK | 0.79858335 |
| 60 | FGFR1 | 0.78205586 |
| 61 | EPHA3 | 0.77659473 |
| 62 | MAP3K2 | 0.76975569 |
| 63 | CAMKK1 | 0.76074193 |
| 64 | RPS6KC1 | 0.75594358 |
| 65 | RPS6KL1 | 0.75594358 |
| 66 | ZAP70 | 0.73189307 |
| 67 | RET | 0.72923095 |
| 68 | NME2 | 0.72466381 |
| 69 | PIM2 | 0.71940782 |
| 70 | TAOK2 | 0.71940088 |
| 71 | FLT3 | 0.71375097 |
| 72 | TESK1 | 0.67977123 |
| 73 | MAP3K1 | 0.67975959 |
| 74 | STK10 | 0.66556698 |
| 75 | BCKDK | 0.65215040 |
| 76 | FGFR2 | 0.65032852 |
| 77 | PRKD3 | 0.64822849 |
| 78 | RPS6KA4 | 0.62289914 |
| 79 | ERBB4 | 0.60646813 |
| 80 | ILK | 0.60507499 |
| 81 | GSK3A | 0.58993452 |
| 82 | MAP2K1 | 0.57747085 |
| 83 | JAK1 | 0.57472450 |
| 84 | TYK2 | 0.57157331 |
| 85 | ARAF | 0.56045228 |
| 86 | PRKD1 | 0.55436957 |
| 87 | TBK1 | 0.55252792 |
| 88 | CSF1R | 0.54206861 |
| 89 | RPS6KA2 | 0.54081505 |
| 90 | RPS6KA6 | 0.53281862 |
| 91 | MAP3K11 | 0.52981981 |
| 92 | ROCK1 | 0.52897801 |
| 93 | KSR2 | 0.52810662 |
| 94 | MAP2K3 | 0.52460099 |
| 95 | TNK2 | 0.52053126 |
| 96 | CDC42BPA | 0.51859407 |
| 97 | CHUK | 0.50848990 |
| 98 | MAP3K14 | 0.50250082 |
| 99 | KSR1 | 0.49765147 |
| 100 | FGFR3 | 0.49031414 |
| 101 | MAPK7 | 0.47954416 |
| 102 | MAP3K7 | 0.46416571 |
| 103 | TYRO3 | 0.43694025 |
| 104 | NEK1 | 0.43409942 |
| 105 | EGFR | 0.43040345 |
| 106 | MAP3K8 | 0.40605347 |
| 107 | MAPKAPK2 | 0.39498695 |
| 108 | SRC | 0.38619581 |
| 109 | ROCK2 | 0.38264694 |
| 110 | JAK2 | 0.37813421 |
| 111 | HIPK2 | 0.37753597 |
| 112 | IRAK2 | 0.37671034 |
| 113 | WNK4 | 0.37440052 |
| 114 | PRKCH | 0.36903214 |
| 115 | RIPK4 | 0.36339818 |
| 116 | TRPM7 | 0.34813040 |
| 117 | BLK | 0.34620071 |
| 118 | TGFBR1 | 0.33479162 |
| 119 | CSK | 0.33095026 |
| 120 | MOS | 0.33036648 |
| 121 | MAPK11 | 0.32659392 |
| 122 | PRKAA1 | 0.32304535 |
| 123 | MAPKAPK3 | 0.31308475 |
| 124 | CDK9 | 0.31264859 |
| 125 | TESK2 | 0.30858309 |
| 126 | CDK7 | 0.30596757 |
| 127 | STK38 | 0.29207434 |
| 128 | PIK3CG | 0.29186362 |
| 129 | INSR | 0.28259142 |
| 130 | MATK | 0.28095438 |
| 131 | STK38L | 0.27815489 |
| 132 | RPS6KB2 | 0.27735173 |
| 133 | PRKG2 | 0.27658086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.56803134 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29333044 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.05299895 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.01544867 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97378857 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94035783 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93476072 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77439112 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75580311 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68957497 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.68838658 |
| 12 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.64041743 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.56305038 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 1.51739140 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51387648 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47707932 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43153131 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 1.40580269 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39489314 |
| 20 | Adherens junction_Homo sapiens_hsa04520 | 1.37241622 |
| 21 | Bladder cancer_Homo sapiens_hsa05219 | 1.32137964 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31599336 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.31178766 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30782201 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28763119 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28393371 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25315364 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23338329 |
| 29 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.22923918 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21952097 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.19594654 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18905903 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17864665 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17556350 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16990504 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15075923 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14678124 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13832752 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13037188 |
| 40 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.08785835 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 1.07972704 |
| 42 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.07946084 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.06085082 |
| 44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06043167 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01695323 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.01541017 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00716199 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99494060 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98557344 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97087192 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96061117 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95588901 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.94132877 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94123812 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93192735 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.92129523 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91721587 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91104003 |
| 59 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89512492 |
| 60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.88576920 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87642366 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87321754 |
| 63 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86994563 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86157356 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85508082 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85437338 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85262207 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84911393 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83288841 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82851313 |
| 71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82646411 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82640092 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81075921 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80480264 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79688863 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.78236766 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77377068 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77348899 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76705719 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.76575295 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76075723 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75042646 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75028095 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.74388971 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73061846 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72829744 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70219379 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68800203 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68522604 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68161777 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66441410 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.66435124 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66173013 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66151064 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64846182 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64760673 |
| 97 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64210400 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64065253 |
| 99 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63433606 |
| 100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62988172 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62348881 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62191769 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62088808 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61986753 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61564459 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.61169142 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.61045866 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.60859697 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60849496 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60787272 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60352464 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59851598 |
| 113 | * Axon guidance_Homo sapiens_hsa04360 | 0.59830168 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59683355 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59662783 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59105542 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.59061509 |
| 118 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58923042 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.58786231 |
| 120 | Hepatitis B_Homo sapiens_hsa05161 | 0.58696133 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58332394 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57532708 |
| 123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57342302 |
| 124 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.57209771 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.57191455 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.57012425 |
| 127 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56914655 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.56185805 |
| 129 | Glioma_Homo sapiens_hsa05214 | 0.55781244 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.55615566 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55595355 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.54975921 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54843327 |
| 134 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54111384 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.52642364 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52602171 |
| 137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52016884 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51280501 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50968089 |
| 140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50572938 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.50414622 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50301812 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50244352 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49662347 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49481866 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48576426 |
| 147 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48532219 |
| 148 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48493164 |
| 149 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47722456 |
| 150 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47509644 |

